Listed

Femasys Inc

FEMYNasdaqCIK 1339005HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$331.8kRevenue, Q2 FY2026, three months to 2026-06-30$331.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 14, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$331.8kRevenue, Q2 FY2026, three months to 2026-06-30$331.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure−18.9% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin−1526.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Revenue: $331.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure−585.6 pts on a year earlier
  • Net margin−1346.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Revenue: $331.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure−226.3 pts on a year earlier
  • Diluted EPS−$1.33Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure+58.2% on a year earlier
  • Free cash flow−$3.9mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001140361-26-033157. Derived: 6-month figure less the 3-month figure.Capital expenditure: $9.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001140361-26-033157. Derived: 6-month figure less the 3-month figure.Report this figure+11.3% on a year earlier

Last eight quarters

Full statements
Revenue$331.8kOperating margin −1526.7%
Diluted EPS−$1.33, Q2 FY2026
Free cash flow−$3.9m, Q2 FY2026
Femasys Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k555Revenue, Q3 FY2024, three months to 2024-09-30$554.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figure582Revenue, Q4 FY2024, three months to 2024-12-31$581.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure341Revenue, Q1 FY2025, three months to 2025-03-31$341.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure409Revenue, Q2 FY2025, three months to 2025-06-30$409.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure729Revenue, Q3 FY2025, three months to 2025-09-30$729.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figure813Revenue, Q4 FY2025, three months to 2025-12-31$813.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure425Revenue, Q1 FY2026, three months to 2026-03-31$424.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure332Revenue, Q2 FY2026, three months to 2026-06-30$331.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%(922.4%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Revenue: $554.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figure(812.0%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Revenue: $581.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure(1600.1%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Revenue: $341.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(941.1%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Revenue: $409.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure(500.9%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Revenue: $729.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figure(568.3%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Revenue: $813.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure(994.0%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Revenue: $424.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(1526.7%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Revenue: $331.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure
Net margin%(974.7%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Revenue: $554.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figure(881.0%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Revenue: $581.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure(1727.9%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Revenue: $341.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(1120.5%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Revenue: $409.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure(575.1%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Revenue: $729.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figure(485.7%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Revenue: $813.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure199.1%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $846.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Revenue: $424.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(1346.8%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Revenue: $331.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure
Diluted EPS$ per share(0.24)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figurenot reported (Diluted EPS not reported)(0.23)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(3.18)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$3.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure(0.10)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001140361-25-042308.Report this figurenot reported (Diluted EPS not reported)0.00Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(1.33)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001140361-26-033157.Report this figure
Free cash flow$k(5,883)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001140361-25-042308. Derived: 9-month figure less the 6-month figure.Capital expenditure: $407.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001140361-25-042308. Derived: 9-month figure less the 6-month figure.Report this figure(5,181)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Capital expenditure: $106.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure(4,862)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Capital expenditure: $96.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(4,447)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001140361-26-033157. Derived: 6-month figure less the 3-month figure.Capital expenditure: $94.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001140361-26-033157. Derived: 6-month figure less the 3-month figure.Report this figure(5,582)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001140361-25-042308. Derived: 9-month figure less the 6-month figure.Capital expenditure: $194.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001140361-25-042308. Derived: 9-month figure less the 6-month figure.Report this figure(4,325)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Capital expenditure: $139.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001140361-26-012375. Derived: 12-month figure less the 9-month figure.Report this figure(4,223)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Capital expenditure: $79.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001140361-26-020115.Report this figure(3,945)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001140361-26-033157. Derived: 6-month figure less the 3-month figure.Capital expenditure: $9.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001140361-26-033157. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$2.3mGross margin not reported
Diluted EPS−$0.47, FY2025
Free cash flow−$19.2m, FY2025
Femasys Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1.2Revenue, FY2021, twelve months to 2021-12-31$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Report this figure1.2Revenue, FY2022, twelve months to 2022-12-31$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-28, accession 0001140361-24-016230.Report this figure1.1Revenue, FY2023, twelve months to 2023-12-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0001140361-25-010598.Report this figure1.6Revenue, FY2024, twelve months to 2024-12-31$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure2.3Revenue, FY2025, twelve months to 2025-12-31$2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure
Gross margin%68.6%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $809.3k. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Report this figure63.4%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $764.3k. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-28, accession 0001140361-24-016230.Report this figurenot reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%(706.7%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Report this figure(961.7%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$11.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-28, accession 0001140361-24-016230.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-28, accession 0001140361-24-016230.Report this figure(1353.4%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001140361-25-010598.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0001140361-25-010598.Report this figure(1091.8%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure(767.0%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$17.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375.Revenue: $2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure
Net margin%(639.0%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Report this figure(944.6%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-28, accession 0001140361-24-016230.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-28, accession 0001140361-24-016230.Report this figure(1329.1%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001140361-25-010598.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0001140361-25-010598.Report this figure(1155.0%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$18.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure(812.3%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$18.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001140361-26-012375.Revenue: $2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure
Diluted EPS$ per share(1.12)Diluted EPS, FY2021, twelve months to 2021-12-31−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Report this figure(0.96)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-28, accession 0001140361-24-016230.Report this figure(0.93)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-27, accession 0001140361-25-010598.Report this figure(0.85)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure(0.47)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure
Free cash flow$m(8.2)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Capital expenditure: $306.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2023-07-24, accession 0001140361-23-035663.Report this figure(11.1)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-28, accession 0001140361-24-016230.Capital expenditure: $407.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-28, accession 0001140361-24-016230.Report this figure(11.4)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001140361-25-010598.Capital expenditure: $143.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0001140361-25-010598.Report this figure(20.2)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001140361-26-012375.Capital expenditure: $761.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure(19.2)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$18.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001140361-26-012375.Capital expenditure: $525.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001140361-26-012375.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Femasys Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Dauntless Investment Group, LLC2026-06-30$7.8m1,867,987New+1,867,987
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$260.1k62,232New+62,232
JANE STREET GROUP, LLC2026-06-30$219.5k52,511New+52,511
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$129.3k30,920New+30,920
UBS Group AG2026-06-30$78.5k18,777New+18,777
CITADEL ADVISORS LLC2026-06-30$70.7k16,921New+16,921
VANGUARD FIDUCIARY TRUST CO2026-06-30$52.2k12,492New+12,492
OSAIC HOLDINGS, INC.2026-06-30$10.0k2,397New+2,397
BlackRock, Inc.2026-06-30$7.5k1,784New+1,784
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO2026-06-30$4.2k1,000New+1,000

Recent filings

All 333 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Femasys Inc, recent filings
FiledFormWhat it isAccession number
2026-08-1720:30 ETSCHEDULE 13DOwnership report, active investor0001104659-26-097888
2026-08-1420:28 ET10-QQuarterly reportPeriod 2026-06-300001140361-26-033157
2026-08-1420:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-26-033145
2026-08-1120:40 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001140361-26-032247
2026-06-2420:05 ET8-K5.07 Shareholder vote results0001140361-26-026239
2026-06-2413:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-26-026169
2026-06-0520:06 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001140361-26-024265
2026-06-0413:00 ET8-K7.01 Regulation FD disclosure0001140361-26-023955
2026-05-1320:48 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-26-021081
2026-05-0820:45 ET10-QQuarterly reportPeriod 2026-03-310001140361-26-020115

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 31, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1339005
Tickers
FEMY
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.